Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 8Phase 3 5Phase 2/3 2Phase 1 2Phase 4 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wrist Fractures 1Triple Negative Breast Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Portal Vein Tumor Thrombus 1Meningiomas of the Middle Cranial Fossa 1Hand Injuries 1Edema 1Dupuytren Contracture 1Disease 1Adenocarcinoma Of Esophagus 1

Interventions

Bismuth 6Esomeprazole 5Amoxicillin 5Tetracycline 4Oxaliplatin 4apatinib 3Irinotecan 3Furazolidone 3Fluorouracil 3Clarithromycin 3fish oil triglycerides 2Rabeprazole 2Leucovorin 2Indocyanine Green 2Berberine 2sintilimab 1potassium oxonate 1lenvatinib 1iron isomaltoside 1000 1ilaprazole 1gimeracil 1ferric carboxymaltose 1doxifluridine 1alanylglutamine 1Water 1Trastuzumab 1Tranexamic Acid 1Tobacco Use Cessation Devices 1Thalidomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Stomach Neoplasms × Surgical Procedures, Operative × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡